Shukur, H. Y. “Long Term Continuous Trastuzumab Use for HER2-Positive Advanced Breast Cancer”. Journal of Contemporary Medical Sciences, vol. 6, no. 5, Oct. 2020, pp. 234-41, doi:10.22317/jcms.v6i5.862.